Nalmefene Challenge to Modulate Neural Reactivity to Alcohol-related and Emotional Cues in Non-treatment Seeking Alcohol Dependent Participants
Phase of Trial: Phase 0
Latest Information Update: 06 Jul 2017
At a glance
- Drugs Nalmefene (Primary)
- Indications Alcoholism
- Focus Pharmacodynamics
- Acronyms NALCUE
- 28 Jun 2017 Status changed from recruiting to discontinued.
- 07 Jan 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Apr 2016, as reported by ClinicalTrials.gov.
- 07 Jan 2016 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.